EU industry challenges hip implants upgrade proposal
This article was originally published in Clinica
Executive Summary
The formal request put forward by the French and UK medical device regulatory authorities to reclassify hip joint replacements as high risk products (see Clinica No 1045, p 3) could impact the availability of these products to patients in the short term and constitute an unnecessary burden on the European medical technology industry. That is the view of the European medical devices industry association, which has issued a statement challenging the nature of the request.